GlassScriptPhysician profile
Thomas M Amidon
NPI 1699736579
$64,268.53
in general payments reported to CMS, 2019-2025
25 companies · $495 in 2025
The $495 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36K · 2020: $11K · 2021: $3,352 · 2022: $3,049 · 2023: $2,637 · 2024: $8,075 · 2025: $495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,885 · Consulting Fee: $4,080 · Food and Beverage: $2,217 · Travel and Lodging: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,885.00 |
| Consulting Fee | $4,080.00 |
| Food and Beverage | $2,216.91 |
| Travel and Lodging | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $19,035.89 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $13,458.33 | 2019-2022 | |
| Siemens Medical Solutions USA, INC. | $9,805.00 | 2019-2024 | Acuson Origin Diagnostic Ultrasound System, Acuson Sequoia Diagnostic Ultrasound System |
| Amarin Pharma, INC. | $8,488.72 | 2020 | |
| Merck Sharp & Dohme LLC | $3,414.51 | 2023-2025 | Verquvo |
| Novo Nordisk INC | $3,243.45 | 2021-2025 | Wegovy |
| Boston Scientific Corporation | $1,584.70 | 2019-2024 | Watchman Access System, Watchman Flx |
| Medtronic Vascular, INC. | $1,378.91 | 2019-2020 | |
| Abiomed | $690.28 | 2022-2025 | Impella |
| Fujifilm Sonosite, INC. | $500.00 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $488.79 | 2019-2025 | Farxiga, Andexxa |
| Janssen Pharmaceuticals, INC | $462.40 | 2019-2024 | Xarelto |
| Shockwave Medical, INC | $419.09 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $296.16 | 2019-2024 | |
| Abbott Laboratories | $282.37 | 2022-2024 | Jeti Peripheral Catheter |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $262.70 | 2020-2025 | |
| Portola Pharmaceuticals, LLC | $129.17 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $123.07 | 2022 | |
| Chiesi USA, INC. | $52.81 | 2022 | |
| Bridgebio Pharma, INC. | $34.86 | 2025 | Attruby |
| Stryker Corporation | $34.33 | 2023 | |
| Amgen INC. | $24.16 | 2025 | Repatha |
| Heartflow, INC. | $23.67 | 2025 | |
| Kestra Medical Technology Services, INC. | $21.93 | 2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.23 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Amidon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.